Cargando…
Limitations of Monitoring Disease Progression Using Circulating Tumor DNA in Lymphoma: An Example From Primary Cutaneous DLBCL Leg-type
Autores principales: | Trethewey, Christopher S., Walter, Harriet S., Alqahtani, Abdullah N. M., Schmid, Ralf, Guttery, David S., Griffin, Yvette, Ahearne, Matthew J., Saldanha, Gerald S., Jayne, Sandrine P. N., Dyer, Martin J. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893288/ https://www.ncbi.nlm.nih.gov/pubmed/35261967 http://dx.doi.org/10.1097/HS9.0000000000000690 |
Ejemplares similares
-
BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib
por: Jackson, Ross A., et al.
Publicado: (2023) -
Primary Cutaneous DLBCL Non-GCB Type: Challenges of a Rare Case
por: Sica, Antonello, et al.
Publicado: (2020) -
Leptomeningeal relapse in primary cutaneous DLBCL: Implications for a prophylactic CNS therapy
por: Sundriyal, Deepak, et al.
Publicado: (2020) -
The Immunology of DLBCL
por: Takahara, Taishi, et al.
Publicado: (2023) -
Computational modeling of DLBCL predicts response to BH3-mimetics
por: Cloete, Ielyaas, et al.
Publicado: (2023)